Therapeutic Solutions International, Inc. (OTCMKTS:TSOI – Get Free Report)’s share price crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $0.00 and traded as high as $0.00. Therapeutic Solutions International shares last traded at $0.00, with a volume of 182,924,719 shares trading hands.
Therapeutic Solutions International Stock Down 25.0 %
About Therapeutic Solutions International
Therapeutic Solutions International, Inc focuses on immune modulation for the treatment of various specific diseases in the United States. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, and traumatic brain injury, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production.
Featured Stories
- Five stocks we like better than Therapeutic Solutions International
- Ride Out The Recession With These Dividend Kings
- Oil Titans Face Off: Exxon Mobil or Chevron for 2025 Gains?
- The Most Important Warren Buffett Stock for Investors: His Own
- Mining Stocks Back in the Spotlight: 3 Key Names to Watch
- Using the MarketBeat Dividend Yield Calculator
- MarketBeat Week in Review – 12/16 – 12/20
Receive News & Ratings for Therapeutic Solutions International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Therapeutic Solutions International and related companies with MarketBeat.com's FREE daily email newsletter.
